Fourth, genetic variation data related to breast and endometrial cancers, such as BRCA and MMR genes, were not available; further studies are needed to confirm the effect of genetic status on the association between tamoxifen use and the risk of uterine diseases. The gene discussed is MRC1; the disease is uterine disorder.